Assessing the diagnostic accuracy of ChatGPT-4 in the histopathological evaluation of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)

被引：0

作者：

Akpinar, Reha ^{[1
,2
]}

Laohawetwanit, Thiyaphat ^{[2
,3
]}

Panzeri, Davide ^{[4
]}

De Carlo, Camilla ^{[1
,2
]}

Belsito, Vincenzo ^{[1
]}

Terracciano, Luigi ^{[1
,2
]}

Aghemo, Alessio ^{[2
,5
]}

Pugliese, Nicola ^{[2
,5
]}

Calderaro, Julien ^{[6
]}

Sironi, Laura ^{[4
]}

Di Tommaso, Luca ^{[2
,7
]}

机构：

[1] IRCCS Humanitas Res Hosp, Dept Pathol, Milan, Italy

[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[3] Thammasat Univ, Div Pathol, Chulabhorn Int Coll Med, Pathum Thani, Thailand

[4] Univ Milano Bicocca, Dept Phys, Milan, Italy

[5] IRCCS Humanitas Res Hosp, Div Internal Med & Hepatol, Dept Gastroenterol, Milan, Italy

[6] Univ Paris Est Creteil, INSERM, IMRB, Creteil, France

[7] Humanitas Univ, IRCCS Humanitas Res Hosp, Dept Pathol, Dept Biomed Sci, Milan, Italy

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-245

引用

页码：S580 / S580

页数：1

共 50 条

[1] INSULIN RESISTANCE IS A PREDICTOR OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND MASLD-ASSOCIATED FIBROSIS
Kim, David S.
Ismail, Mohamed
Abboud, Yazan
Khan, Wajiha
Le, Alexander
Pyrsopoulos, Nikolaos T.
Kim, Hyunseok
Hajifathalian, Kaveh
GASTROENTEROLOGY, 2024, 166 (05) : S1657 - S1657
[2] Evolutionary aspects of metabolic dysfunction-associated steatotic liver disease (MASLD)
Geier, Andreas
Schiffels, Stephan
Krawczyk, Marcin
GASTROENTEROLOGIE, 2025,
[3] Evaluation of a Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Clinical Pharmacy Service
Sallam, Sandy
Ahmed, Aijaz
Gu, Xin
DIABETES, 2024, 73
[4] Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italian women: is liver fibrosis independent from menopause?
Chen, R.
Salamone, A.
Abbati, C.
Capelli, R.
Santangeli, E.
Stefanini, B.
Indre, M. G.
Ravaioli, F.
Piscaglia, F.
Ferri, S.
DIGESTIVE AND LIVER DISEASE, 2025, 57
[5] Real world evaluation of a primary care pathway for the assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)
Ahmad, Basil
Mitchell, Oliver
Pannifex, Sally
Singanayagam, Arjuna
Hughes, Sarah
Clark, Sarah
Yalcin, Metin
Williams, Nicola
Davie, Sarah
Forton, Daniel
JOURNAL OF HEPATOLOGY, 2024, 80 : S523 - S523
[6] Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Liu, Huan
Yerevanian, Armen
Westerhoff, Maria
Hastings, Margaret H.
Guerra, Justin Ralph Baldovino
Zhao, Meng
Svensson, Katrin J.
Cai, Bishuang
Soukas, Alexander A.
Rosenzweig, Anthony
DIABETES, 2024, 73 (02) : 260 - 279
[7] Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings
Iruzubieta, Paula
Santos-Laso, Alvaro
Arias-Loste, Maria Teresa
Calleja, Jose Luis
Crespo, Javier
JOURNAL OF HEPATOLOGY, 2024, 80 (03) : e121 - e123
[8] Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)
Iturbe-Rey, Santiago
Maccali, Claudia
Arrese, Marco
Aspichueta, Patricia
Oliveira, Claudia P.
Castro, Rui E.
Lapitz, Ainhoa
Izquierdo-Sanchez, Laura
Bujanda, Luis
Perugorria, Maria J.
Banales, Jesus M.
Rodrigues, Pedro M.
ATHEROSCLEROSIS, 2025, 400
[9] Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine MASLD
Stefan, Norbert
Targher, Giovanni
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2025, : 226 - 227
[10] Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
Kasprzak-Drozd, Kamila
Nizinski, Przemyslaw
Kasprzak, Paulina
Kondracka, Adrianna
Oniszczuk, Tomasz
Rusinek, Agata
Oniszczuk, Anna
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)

← 1 2 3 4 5 →